Literature DB >> 9865612

Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis.

M F Blankenvoorde1, W van't Hof, E Walgreen-Weterings, T J van Steenbergen, H S Brand, E C Veerman, A V Nieuw Amerongen.   

Abstract

We investigated whether cystatins and cystatin-derived peptides, encompassing sequences of secondary structures of cystatin S and papain binding domains of cystatin C, display antimicrobial properties. Of the different microorganisms tested, only the growth of P. gingivalis was inhibited by chicken cystatin and cystatin C. Cystatin S, cystatin S:1-14, cystatin S:61-73 and cystatin S:108-121 also inhibited its growth, whereas cystatin S:21-38, cystatin S:39-55, cystatin S:81-95, cystatin S:94-109, and cystatin C: 9-12/55-60/106-107 did not. No inhibition of the cysteine proteinase activity of P. gingivalis was observed for all cystatin-derived peptides. On the other hand, leupeptin and antipain inhibited P. gingivalis proteinase activity, but had no effect on the growth. These data suggest that cystatins contain antibacterial sequences active against P. gingivalis and that the growth inhibition does not depend on the inhibition of P. gingivalis cysteine proteinases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865612

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  25 in total

1.  Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Authors:  D Grenier; S Imbeault; P Plamondon; G Grenier; K Nakayama; D Mayrand
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease.

Authors:  Snigdha Mukherjee; Anindita Ukil; Pijush K Das
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

Review 3.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

4.  Potential biomarkers of human salivary function: a modified proteomic approach.

Authors:  J D Rudney; R K Staikov; J D Johnson
Journal:  Arch Oral Biol       Date:  2008-09-18       Impact factor: 2.633

Review 5.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

6.  Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli.

Authors:  Suresh Yenugu; Katherine G Hamil; Charles E Birse; Steven M Ruben; Frank S French; Susan H Hall
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

7.  Effect of protease inhibitors on the quantitative and qualitative assessment of oral microorganisms.

Authors:  Gaoxia Liu; Deepak Saxena; Haiteng Deng; Robert G Norman; Zhou Chen; Williams R Abrams; Daniel Malamud; Yihong Li
Journal:  FEMS Microbiol Lett       Date:  2010-09-10       Impact factor: 2.742

8.  Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids.

Authors:  T Kariu; R Nakao; T Ikeda; K Nakashima; J Potempa; T Imamura
Journal:  J Periodontal Res       Date:  2016-03-09       Impact factor: 4.419

9.  The Human Salivary Antimicrobial Peptide Profile according to the Oral Microbiota in Health, Periodontitis and Smoking.

Authors:  Melissa Grant; Ola Kilsgård; Sigvard Åkerman; Björn Klinge; Ryan T Demmer; Johan Malmström; Daniel Jönsson
Journal:  J Innate Immun       Date:  2018-11-28       Impact factor: 7.349

Review 10.  Antimicrobial peptides: natural effectors of the innate immune system.

Authors:  Katherine Radek; Richard Gallo
Journal:  Semin Immunopathol       Date:  2007-04       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.